Evizon squalamine lactate: Phase II data

In the open-label, U.S. Phase II MSI-1256F-207 trial in 18 patients, 17% of the study eyes that received 20 mg Evizon had >=3 lines vision improvement, and 83% had stable or improved vision at month 4...